TCM for Chronic Kidney Disease: Kidney Qi and Yang Deficiency Patterns, the Astragalus Evidence, Safe Acupressure, and the Herbs Kidney Patients Must Avoid (2026 Guide)

Cover image source: Pexels (photo by Elena Golovchenko)

An autumn evening with your lab results

It is late October, and the light has faded before dinner. You open your lab portal and compare this month’s creatinine, estimated glomerular filtration rate (eGFR), and urine albumin with the previous results. Perhaps you feel much the same. The numbers still raise questions: what matters over time, what might help with itching or poor sleep, and whether a traditional herb is safe alongside your prescriptions.

Those questions deserve separate answers. A change in a laboratory marker, relief from itching, and avoidance of kidney failure are different outcomes. Research showing one does not automatically establish the others.

This article is education, not diagnosis. CKD management belongs to a nephrologist, working with your primary care clinician and other specialists. Every herb or formula must be cleared with your care team because drug interactions and potassium or phosphorus loads can matter. Bring the actual package and ingredient list, not just the product’s translated name.

What CKD means, and why two categories matter

KDIGO defines chronic kidney disease as abnormalities of kidney structure or function lasting at least three months and affecting health. Classification combines cause, GFR category, and albuminuria category, abbreviated CGA. One unexpected result alone does not establish chronicity. KDIGO 2024 CKD guideline

G1 or G2 alone does not establish CKD without another marker of kidney damage. Urine albumin-to-creatinine ratio (UACR) adds information: A1 is below 30 mg/g, normal to mildly increased; A2 is 30–300 mg/g, moderately increased; A3 is above 300 mg/g, severely increased. Read these categories together. KDIGO classification tables

For CKD G3–G5, Recommendation 2.2.1 calls for an externally validated equation to estimate absolute kidney failure risk, graded 1A. A practice point says a five-year risk of 3%–5% can help guide nephrology referral alongside other clinical considerations. Ask your clinician what your combined results mean and when to repeat them; a traditional pattern label cannot provide this risk estimate. KDIGO risk assessment

The TCM frame: traditional patterns, not kidney-function tests

In traditional Chinese medicine, the “kidney” belongs to a broader functional vocabulary than the anatomical organs measured by eGFR. Kidney qi and yang are traditional concepts, not substances measured in blood. Our guide to kidney jing and traditional kidney health explains that vocabulary further.

A practitioner may discuss these patterns:

• Kidney qi deficiency: Traditionally associated with reduced stamina, lower-back weakness, and changes in urination. It does not establish reduced filtration.
• Kidney yang deficiency: A traditional description emphasizing coldness, low energy, and difficulty managing fluids. Feeling cold is not enough to identify this pattern or diagnose CKD.
• Spleen-kidney yang deficiency: Traditionally combines digestive weakness, loose stools, coldness, and swelling. “Spleen” here is also a traditional functional term.
• Damp-heat: Traditionally describes combinations of heaviness and heat signs, sometimes with urinary discomfort. Burning urination or fever requires medical assessment rather than a self-selected heat-clearing formula.
• Blood stasis: Traditionally refers to impaired movement of blood within the TCM framework, often described through fixed discomfort or dark coloration. It does not mean a blood clot has been diagnosed.

These are traditional categories, not biomedical diagnoses or a checklist for selecting herbs. Fatigue, swelling, and urinary changes need medical interpretation even when a practitioner also describes a pattern. Several patterns may be discussed in one person, and none maps reliably onto a GFR stage.

The kidney stone and damp-heat guide addresses a different clinical problem. Do not transfer its stone-prevention fluid advice to CKD, especially if you have a prescribed fluid limit.

What the astragalus evidence actually shows

Cochrane: encouraging markers, low-quality evidence

The 2014 Cochrane review by Zhang and colleagues included 22 studies and 1,323 participants, including 241 receiving dialysis. Risk of bias was high in six studies and unclear in 16; overall evidence quality was low. No included study reported time to renal replacement therapy or all-cause mortality. Cochrane review CD008369

Reported pooled results included:

• Creatinine clearance: mean difference +5.75 mL/min, 95% confidence interval 3.16–8.34; four studies, 306 participants.
• Protein lost in urine over 24 hours: mean difference −0.53 g/24 h, 95% confidence interval −0.79 to −0.26; ten studies, 640 participants. Heterogeneity was substantial, I²=90%.
• Hemoglobin: mean difference +9.51 g/L, 95% confidence interval 4.90–14.11; four studies, 222 participants.

These are promising laboratory findings, but weaknesses in methods and reporting limit confidence. Creatinine clearance is not interchangeable with every eGFR measurement, and less proteinuria is not proof that dialysis was delayed. The review does not establish definitive benefit or dependable long-term safety. Cochrane findings and limitations

The 2024 Hong Kong trial: a more focused result

Chan and colleagues studied 118 patients with type 2 diabetes and CKD in a multicenter, assessor-blind randomized trial. Entry criteria included eGFR 30–90 mL/min/1.73 m² and UACR 300–5,000 mg/g. Over 48 weeks, oral astragalus granules were added to usual care at a daily raw-herb equivalent of 15 g. This describes the study, not a self-treatment dose. Phytomedicine trial, PMID 38810556; NCT03535935

The eGFR decline slope was 4.6 mL/min/1.73 m² per year slower with astragalus, with a 95% confidence interval of 1.5–7.6 and p=0.003. The UACR slope difference was not significant: 1.14, 95% confidence interval 0.85–1.52, p=0.392. Endpoint systolic blood pressure was 7.9 mmHg lower, with a 95% confidence interval of −12.9 to −2.8 and p=0.003. There were 117 adverse events across 31 astragalus-group and 41 control-group patients. These counts do not establish that every event was caused by treatment. Trial results

The single ethnic-region population, specific diabetic CKD population, and limited follow-up constrain generalization. Assessor blinding is not full participant blinding. Astragalus remains an adjunct, not a replacement for standard care; these results cannot be assumed for untested commercial formulas.

Keep established kidney care in place

KDIGO Recommendation 3.6.1 recommends an ACE inhibitor or ARB, collectively RAS inhibitors, for CKD G1–G4 with A3 albuminuria without diabetes, graded 1B. Recommendation 3.7.1 recommends an SGLT2 inhibitor for type 2 diabetes with CKD and eGFR at least 20 mL/min/1.73 m², graded 1A. These are clinician-directed treatments with monitoring requirements. KDIGO treatment recommendations

Do not stop or reduce prescribed medicine to try herbs, and do not replace RAS inhibitors or SGLT2 inhibitors with astragalus. Ask your care team how any proposed supplement would fit your current treatment and laboratory monitoring. Readers managing both conditions can also consult our TCM and blood sugar guide, keeping their diabetes treatment plan central.

Acupuncture and acupressure: symptom evidence has limits

Itching is the clearest question in these reviews

Uremic pruritus is itching associated with kidney disease. A systematic review of complementary treatments examined 21 treatments, including five acupuncture studies, four topical capsaicin studies, and three acupressure studies. These approaches had the largest relevant bodies of evidence highlighted by the authors, who called for larger, higher-quality randomized trials. Reported acupuncture adverse events included soreness in 7.5%, bleeding in 6.0%–7.5%, and hematoma in 1.9%. These are study reports, not a personalized risk prediction. Uremic pruritus systematic review

A 2024 network meta-analysis found acupuncture combined with conventional treatment most promising for dialysis-associated itching, while emphasizing the need for better trials. Rankings from a network analysis do not remove concerns about risk of bias in the underlying studies, including how treatment allocation and blinding were handled. Frontiers in Neurology review

In Karjalian and colleagues’ acupressure trial involving 90 hemodialysis patients, itch severity fell significantly in both the intervention and sham groups, p=0.001. End-of-study between-group differences were reported for serum phosphorus, p=0.045, and parathyroid hormone, p=0.004. The sham response makes expectation and other nonspecific effects plausible; improvement within a group alone does not prove a point-specific effect. Acupressure trial, PMID 32497714

Fatigue and sleep need their own assessment

The itch-focused reviews above do not establish reliable treatment effects for CKD fatigue or insomnia. Itch relief may make an evening more comfortable, but it should not be relabeled as proven sleep treatment. Report persistent fatigue, restless nights, or worsening itch to your kidney team so they can assess causes and treatment options.

If considering acupuncture, use a qualified practitioner who coordinates with your dialysis or kidney team. Discuss anticoagulants, bleeding tendency, and infection precautions. Never needle yourself. Evidence from practitioner acupuncture also cannot be transferred automatically to a home finger-pressure routine.

A short, gentle acupressure routine

Acupressure is optional comfort care for symptoms only. It does not treat kidney function decline. The sequence below is not a validated CKD treatment protocol and has not been shown to improve eGFR, remove retained waste, or replace dialysis.

Protect access sites before choosing points

Never apply acupressure or massage anywhere on the arm with an arteriovenous fistula or graft, and never press on a dialysis catheter site. Never press on the abdomen over a peritoneal dialysis catheter. Avoid swollen, bruised, infected, broken, or irritated skin. These restrictions take priority over every point location below.

Ask the care team first if you have reduced sensation, fragile skin, easy bleeding, or difficulty judging pressure. Skip any location you cannot identify comfortably. Do not perform this routine during dialysis unless your dialysis team explicitly approves it.

Five traditional locations in plain English

These landmarks identify traditional points, not proven kidney treatments. A qualified practitioner can show you their positions without pressing on vulnerable areas.

• Yintang: The midpoint between the inner ends of your eyebrows. Rest a fingertip here lightly, away from the eyes.
• PC6, Neiguan: On the palm side of the forearm, roughly three finger-widths above the wrist crease, between the central tendons. Use only an arm without a fistula, graft, or other access restriction.
• HT7, Shenmen: At the wrist crease on the little-finger side, in the small hollow just toward the thumb from the prominent tendon. Again, skip the entire access arm.
• ST36, Zusanli: About four finger-widths below the lower edge of the kneecap and one finger-width to the outside of the shinbone, in the muscle rather than on the bone.
• KI3, Taixi: In the hollow between the inner ankle bone and the Achilles tendon. Skip this point if the ankle is swollen or the skin is fragile.

Sit comfortably. Choose only the safe, accessible points and apply light, painless pressure for about 20 seconds each, with a relaxed breath between points. One pass is enough to see whether the touch feels pleasant; there is no need to complete every location or repeat on both sides. This timing is a practical suggestion, not a research-derived dose.

Stop immediately for pain, tingling, dizziness, skin discoloration, or discomfort. Avoid tools, deep massage, and attempts to produce a strong sensation. Simply resting with relaxed breathing is an acceptable alternative when pressure is unsuitable.

Food and daily habits: use your renal plan

Ask your renal dietitian to translate your laboratory results and treatment needs into meals you actually eat. Reduce sodium as advised. Potassium and phosphorus limits should reflect your results; protein needs depend partly on dialysis status. Fluid intake also needs an individual target. TCM food advice must never override a renal dietitian’s potassium or phosphorus limits. KDIGO guidance on individualized dietary care

A useful appointment list includes your usual soup portions, herbal drinks, salt substitutes, protein supplements, and foods you have started avoiding. Ask whether each fits your plan. Do not assume that a food described as “kidney nourishing” is appropriate in unlimited amounts, or that a large bowl of broth falls outside a fluid allowance.

Keep prescribed medicines and appointments organized. Ask which home observations your team wants recorded, such as blood pressure, weight changes, sleep, or itch. Bring the record to follow-up rather than reacting to every isolated number with a new supplement. Choose manageable activity and rest within your clinician’s advice, and make any agreed routine simple enough to maintain through busy weeks.

What kidney patients must not take on their own

Aristolochic acid is a firm avoidance rule

Aristolochic acid is a potent kidney toxin and carcinogen associated with aristolochic acid nephropathy. The FDA’s import alert addresses detention of products containing Aristolochia and other aristolochic-acid-containing botanicals. Misidentification and confusion between traditional names have contributed to exposure. FDA Import Alert 54-10

Upper urinary tract and bladder cancers have been reported after exposure associated with kidney damage. The National Cancer Institute advises avoiding products containing aristolochic acids. Do not assume that a familiar Chinese name, a “natural” label, or a seller’s reassurance establishes botanical identity or safety. NCI aristolochic acid guidance

Avoid unknown products and unreviewed combinations

Do not take unknown-source powders, unlabeled pills, or formulas whose full ingredients and source cannot be checked. High-potassium herbal decoctions are unsuitable for self-experimentation; a preparation’s potassium or phosphorus contribution may not be apparent from its name. Clear all formulas with the kidney team, including products previously tolerated before CKD developed.

Do not self-start NSAID pain relievers such as ibuprofen or naproxen. Ask your clinician which pain medicine is appropriate, and never independently stop a prescribed medication. Include over-the-counter products in medication reviews. KDIGO medication stewardship

A useful review needs the product label, botanical names, amount, frequency, manufacturer, and every prescription you take. If that information is unavailable, leave the product unused. A traditional pattern assessment does not replace this safety review, and a favorable astragalus trial does not establish the safety of a multi-herb mixture.

Red flags that need urgent care

Seek urgent medical assessment for any of the following. Call emergency services for chest pain, severe breathlessness, or altered alertness; do not delay to try herbs or acupressure.

• Very low urine output, especially a marked new decrease from your usual pattern.
• Swelling accompanied by breathlessness.
• Vomiting with confusion or drowsiness.
• Chest pain.
• Fever with a dialysis access site that is warm or red.
• Sudden severe flank pain with blood in the urine.

Some dialysis patients normally make little urine; a new change or accompanying illness still needs assessment. A warm, red access with fever requires urgent attention even if the skin changes look small. Keep your dialysis unit’s urgent contact instructions available, and use emergency care when symptoms are severe or timely advice is unavailable.

A realistic place for traditional care

At the next review, bring your lab trend, symptom notes, and any proposed herb label. Ask what outcome you would be trying to improve and how benefit or harm would be monitored. Traditional language may help you discuss your experience, and gentle touch may offer a moment of comfort. Neither changes the need for nephrology care. The practical goal is a safer, more manageable routine with clear follow-up and realistic expectations.